North America Bioprinting Market

North America Bioprinting Market size was valued at USD 0.7 billion in 2025 and is forecast to grow from USD 0.8 billion in 2026 to reach USD 1.5 billion by 2031, at a CAGR of 15.9%.

Description

The North America Bioprinting Market size was valued at USD 0.7 billion in 2025 and is forecast to grow from USD 0.8 billion in 2026 to reach USD 1.5 billion by 2031, at a CAGR of 15.9%. Bioprinting is an additive-manufacturing process that precisely deposits layers of living cells, biomaterials, and growth factors to fabricate functional tissue constructs, vascular grafts, and organ models used in regenerative medicine, drug discovery, and tissue-transplantation research. The market sits at the intersection of tissue engineering, additive manufacturing, and regenerative medicine, making it one of the most closely watched enabling technologies across the regional biotechnology and advanced-healthcare value chain.

Demand for bioprinting platforms remains anchored by persistent organ-donor shortages, expanding public and private research funding for regenerative medicine, and rising pharmaceutical interest in bioprinted tissue models that reduce reliance on animal testing across the United States, Canada, and Mexico. Beyond regenerative medicine, bioprinting continues to enable applications in drug-toxicity screening, personalized organoid development, and tissue and organ transplantation research that require precise, patient-specific biological fabrication. Rising healthcare and biotechnology R&D expenditure, expanding federal research initiatives, and continued advances in bio-ink formulation and vascularization technology are sustaining consumption even as the region transitions from experimental research toward early clinical translation.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • North America Bioprinting Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology (Extrusion-Based Bioprinting, Inkjet-Based Bioprinting, Laser-Assisted Bioprinting, Others)

      2. By Application (Regenerative Medicine, Drug Discovery & Toxicology Testing, Tissue & Organ Transplantation, Others)

      3. By End User (Hospitals & Transplant Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • United States Bioprinting Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

  • Canada Bioprinting Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

  • Mexico Bioprinting Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • North America Bioprinting Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Organovo Holdings, Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. CELLINK (BICO Group AB)

    3. 3D Systems Corporation

    4. Aspect Biosystems Ltd.

    5. Advanced Solutions Life Sciences, Inc.

    6. Allevi, Inc. (3D Systems)

    7. Poietis SAS

    8. RegenHU Ltd.

    9. TeVido BioDevices, Inc.

    10. Prellis Biologics, Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology